PHRENILIN®: Each PHRENILIN® tablet for oral administration, contains Butalbital, USP 50 mg, Acetaminophen, USP 325 mg.
PHRENILIN® tablets and PHRENILIN® FORTE capsules are indicated for the relief of the symptom complex of tension (or muscle contraction) headache.
Evidence supporting the efficacy and safety of this combination product in the treatment of multiple recurrent headaches is unavailable. Caution in this regard is required because butalbital is habitforming and potentially abusable.
Media Articles Related to Phrenilin (Butalbital / Acetaminophen)
Source: MedicineNet Brain Aneurysm Specialty [2015.03.20]
Category: Symptoms and Signs
Created: 10/13/2003 12:00:00 AM
Last Editorial Review: 3/20/2015 12:00:00 AM
Small clinical study finds electroCore's non-invasive vagus nerve stimulation is effective in treating cluster headaches
Source: Headache / Migraine News From Medical News Today [2015.03.05]
A twelve-month open-label study in the March issue of the journal Neurology, reports that electroCore's non-invasive Vagus Nerve stimulation (nVNS) device, gammaCore, is practical and effective as...
Headache Pictures Slideshow: Surprising Headache and Migraine Triggers
Source: MedicineNet Brain Tumor Specialty [2015.03.05]
Title: Headache Pictures Slideshow: Surprising Headache and Migraine Triggers
Created: 5/18/2009 12:00:00 AM
Last Editorial Review: 3/5/2015 12:00:00 AM
Headaches Quiz: Test Your Headache Pain IQ
Source: MedicineNet codeine Specialty [2015.02.23]
Title: Headaches Quiz: Test Your Headache Pain IQ
Category: MedicineNet Quiz
Created: 9/28/2010 11:09:00 AM
Last Editorial Review: 2/23/2015 12:22:07 PM
Source: MedicineNet Brain Aneurysm Specialty [2015.02.02]
Title: Cluster Headaches
Category: Diseases and Conditions
Created: 2/4/2005 12:00:00 AM
Last Editorial Review: 2/2/2015 12:00:00 AM
Published Studies Related to Phrenilin (Butalbital / Acetaminophen)
Sumatriptan-Naproxen and Butalbital: A Double-Blind, Placebo-Controlled Crossover Study. [2011.11.21]
Objectives.- The primary objective was to compare the efficacy of a sumatriptan and naproxen combination medication (SumaRT/Nap-85 mg sumatriptan and 500 mg naproxen sodium), a butalbital-containing combination medication (BCM-50 mg butalbital, 325 mg acetaminophen, 40 mg caffeine), and placebo when used to treat moderate to severe migraine headache pain in subjects who used BCMs in the past.
Butalbital in the treatment of headache: history, pharmacology, and efficacy. [2001.11]
Analgesics containing butalbital compounded with aspirin, acetaminophen, and/or caffeine are widely used for the treatment of migraine and tension-type headache. The butalbital-containing compounds are efficacious in placebo-controlled trials among patients with episodic tension-type headaches.Because of concerns about overuse, medication-overuse headache, and withdrawal, their use should be limited and carefully monitored.
Page last updated: 2015-03-20